Global Artificial Pancreas Device System (APDS) Market Research Report 2023

Publication ID:

PB502232332

Publication Date:

February 6, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
Highlights
The global Artificial Pancreas Device System (APDS) market was valued at US$ 81 million in 2022 and is anticipated to reach US$ 160.2 million by 2029, witnessing a CAGR of 12.1% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The classification of artificial pancreas devices systems includes threshold suspended device systems and hybrid closed-loop APDS, and the proportion of artificial pancreas devices systems in 2017 is about 60%, and the proportion is in decreasing trend from 2013 to 2017.
Artificial pancreas devices systems are widely used in hospital and clinic. The most proportion of artificial pancreas devices systems is in hospital, and the proportion in 2017 is about 59%.
North America is the largest consumption place, with a consumption market share nearly 54% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.
Market competition is intense. Medtronic is the leader of the industry, and it holds key technologies and patents, with high-end customers; has been formed in the monopoly position in the industry.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Pancreas Device System (APDS), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Pancreas Device System (APDS).
The Artificial Pancreas Device System (APDS) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Artificial Pancreas Device System (APDS) market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Pancreas Device System (APDS) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Segment by Type
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Pancreas Device System (APDS) companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Pancreas Device System (APDS) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Threshold Suspended Device Systems
1.2.3 Hybrid Closed-loop APDS
1.2.4 Other Systems
1.3 Market by Application
1.3.1 Global Artificial Pancreas Device System (APDS) Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Pancreas Device System (APDS) Market Perspective (2018-2029)
2.2 Artificial Pancreas Device System (APDS) Growth Trends by Region
2.2.1 Global Artificial Pancreas Device System (APDS) Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Pancreas Device System (APDS) Historic Market Size by Region (2018-2023)
2.2.3 Artificial Pancreas Device System (APDS) Forecasted Market Size by Region (2024-2029)
2.3 Artificial Pancreas Device System (APDS) Market Dynamics
2.3.1 Artificial Pancreas Device System (APDS) Industry Trends
2.3.2 Artificial Pancreas Device System (APDS) Market Drivers
2.3.3 Artificial Pancreas Device System (APDS) Market Challenges
2.3.4 Artificial Pancreas Device System (APDS) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Pancreas Device System (APDS) Players by Revenue
3.1.1 Global Top Artificial Pancreas Device System (APDS) Players by Revenue (2018-2023)
3.1.2 Global Artificial Pancreas Device System (APDS) Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Pancreas Device System (APDS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Pancreas Device System (APDS) Revenue
3.4 Global Artificial Pancreas Device System (APDS) Market Concentration Ratio
3.4.1 Global Artificial Pancreas Device System (APDS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Pancreas Device System (APDS) Revenue in 2022
3.5 Artificial Pancreas Device System (APDS) Key Players Head office and Area Served
3.6 Key Players Artificial Pancreas Device System (APDS) Product Solution and Service
3.7 Date of Enter into Artificial Pancreas Device System (APDS) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Pancreas Device System (APDS) Breakdown Data by Type
4.1 Global Artificial Pancreas Device System (APDS) Historic Market Size by Type (2018-2023)
4.2 Global Artificial Pancreas Device System (APDS) Forecasted Market Size by Type (2024-2029)
5 Artificial Pancreas Device System (APDS) Breakdown Data by Application
5.1 Global Artificial Pancreas Device System (APDS) Historic Market Size by Application (2018-2023)
5.2 Global Artificial Pancreas Device System (APDS) Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Artificial Pancreas Device System (APDS) Market Size (2018-2029)
6.2 North America Artificial Pancreas Device System (APDS) Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Artificial Pancreas Device System (APDS) Market Size by Country (2018-2023)
6.4 North America Artificial Pancreas Device System (APDS) Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Pancreas Device System (APDS) Market Size (2018-2029)
7.2 Europe Artificial Pancreas Device System (APDS) Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Artificial Pancreas Device System (APDS) Market Size by Country (2018-2023)
7.4 Europe Artificial Pancreas Device System (APDS) Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Pancreas Device System (APDS) Market Size (2018-2029)
8.2 Asia-Pacific Artificial Pancreas Device System (APDS) Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Artificial Pancreas Device System (APDS) Market Size by Region (2018-2023)
8.4 Asia-Pacific Artificial Pancreas Device System (APDS) Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Pancreas Device System (APDS) Market Size (2018-2029)
9.2 Latin America Artificial Pancreas Device System (APDS) Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Artificial Pancreas Device System (APDS) Market Size by Country (2018-2023)
9.4 Latin America Artificial Pancreas Device System (APDS) Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Pancreas Device System (APDS) Market Size (2018-2029)
10.2 Middle East & Africa Artificial Pancreas Device System (APDS) Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Artificial Pancreas Device System (APDS) Market Size by Country (2018-2023)
10.4 Middle East & Africa Artificial Pancreas Device System (APDS) Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Artificial Pancreas Device System (APDS) Introduction
11.1.4 Medtronic Revenue in Artificial Pancreas Device System (APDS) Business (2018-2023)
11.1.5 Medtronic Recent Development
11.2 Bigfoot Biomedical
11.2.1 Bigfoot Biomedical Company Detail
11.2.2 Bigfoot Biomedical Business Overview
11.2.3 Bigfoot Biomedical Artificial Pancreas Device System (APDS) Introduction
11.2.4 Bigfoot Biomedical Revenue in Artificial Pancreas Device System (APDS) Business (2018-2023)
11.2.5 Bigfoot Biomedical Recent Development
11.3 Beta Bionics
11.3.1 Beta Bionics Company Detail
11.3.2 Beta Bionics Business Overview
11.3.3 Beta Bionics Artificial Pancreas Device System (APDS) Introduction
11.3.4 Beta Bionics Revenue in Artificial Pancreas Device System (APDS) Business (2018-2023)
11.3.5 Beta Bionics Recent Development
11.4 Admetsys
11.4.1 Admetsys Company Detail
11.4.2 Admetsys Business Overview
11.4.3 Admetsys Artificial Pancreas Device System (APDS) Introduction
11.4.4 Admetsys Revenue in Artificial Pancreas Device System (APDS) Business (2018-2023)
11.4.5 Admetsys Recent Development
11.5 Insulet
11.5.1 Insulet Company Detail
11.5.2 Insulet Business Overview
11.5.3 Insulet Artificial Pancreas Device System (APDS) Introduction
11.5.4 Insulet Revenue in Artificial Pancreas Device System (APDS) Business (2018-2023)
11.5.5 Insulet Recent Development
11.6 Tandem Diabetes Care
11.6.1 Tandem Diabetes Care Company Detail
11.6.2 Tandem Diabetes Care Business Overview
11.6.3 Tandem Diabetes Care Artificial Pancreas Device System (APDS) Introduction
11.6.4 Tandem Diabetes Care Revenue in Artificial Pancreas Device System (APDS) Business (2018-2023)
11.6.5 Tandem Diabetes Care Recent Development
11.7 Defymed
11.7.1 Defymed Company Detail
11.7.2 Defymed Business Overview
11.7.3 Defymed Artificial Pancreas Device System (APDS) Introduction
11.7.4 Defymed Revenue in Artificial Pancreas Device System (APDS) Business (2018-2023)
11.7.5 Defymed Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂